{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:22:02Z","timestamp":1790324522629,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12957-017-1148-x","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T09:24:04Z","timestamp":1492507444000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Medical treatment of mammary desmoid-type fibromatosis: which benefit?"],"prefix":"10.1186","volume":"15","author":[{"given":"Louise","family":"Scheer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7593-6378","authenticated-orcid":false,"given":"Massimo","family":"Lodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Moli\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Emmanuel","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Mathelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,18]]},"reference":[{"key":"1148_CR1","volume-title":"WHO classification of tumours of soft tissue and bone (IARC WHO classification of tumours)","author":"CDM Fletcher","year":"2013","unstructured":"Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F. WHO classification of tumours of soft tissue and bone (IARC WHO classification of tumours). 4th ed. 2013.","edition":"4"},{"key":"1148_CR2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/ijc.25664","volume":"129","author":"MH Nieuwenhuis","year":"2011","unstructured":"Nieuwenhuis MH, Casparie M, Mathus-Vliegen LM, Dekkers OM, Hogendoorn PC, Vasen HF. A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses. Int J Cancer. 2011;129:256\u201361.","journal-title":"Int J Cancer"},{"key":"1148_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/0002-9610(86)90076-0","volume":"151","author":"JJ Reitamo","year":"1986","unstructured":"Reitamo JJ, Scheinin TM, Hayry P. The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor. Am J Surg. 1986;151:230\u20137.","journal-title":"Am J Surg"},{"key":"1148_CR4","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1634\/theoncologist.2010-0281","volume":"16","author":"B Kasper","year":"2011","unstructured":"Kasper B, Strobel P, Hohenberger P. Desmoid tumors: clinical features and treatment options for advanced disease. Oncologist. 2011;16:682\u201393.","journal-title":"Oncologist"},{"key":"1148_CR5","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1245\/s10434-015-4632-y","volume":"22","author":"DL Broekhoven van","year":"2015","unstructured":"van Broekhoven DL, Grunhagen DJ, den Bakker MA, van Dalen T, Verhoef C. Time trends in the incidence and treatment of extra-abdominal and abdominal aggressive fibromatosis: a population-based study. Ann Surg Oncol. 2015;22:2817\u201323.","journal-title":"Ann Surg Oncol"},{"key":"1148_CR6","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.jgyn.2015.09.033","volume":"44","author":"V Lavoue","year":"2015","unstructured":"Lavoue V, Fritel X, Antoine M, Beltjens F, Bendifallah S, Boisserie-Lacroix M, Boulanger L, Canlorbe G, Catteau-Jonard S, Chabbert-Buffet N, et al. [Benign breast tumors: recommendations of College National des Gynecologues Obstetriciens Francais (CNGOF)\u2014short text]. J Gynecol Obstet Biol Reprod (Paris). 2015;44:1049\u201364.","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"1148_CR7","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1517::AID-CNCR3>3.0.CO;2-9","volume":"88","author":"JJ Nuyttens","year":"2000","unstructured":"Nuyttens JJ, Rust PF, Thomas Jr CR, Turrisi 3rd AT. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles. Cancer. 2000;88:1517\u201323.","journal-title":"Cancer"},{"key":"1148_CR8","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.athoracsur.2004.03.015","volume":"78","author":"AE Abbas","year":"2004","unstructured":"Abbas AE, Deschamps C, Cassivi SD, Nichols 3rd FC, Allen MS, Schleck CD, Pairolero PC. Chest-wall desmoid tumors: results of surgical intervention. Ann Thorac Surg. 2004;78:1219\u201323. discussion 1219\u20131223.","journal-title":"Ann Thorac Surg"},{"key":"1148_CR9","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<2045::AID-CNCR23>3.0.CO;2-F","volume":"86","author":"NB Merchant","year":"1999","unstructured":"Merchant NB, Lewis JJ, Woodruff JM, Leung DH, Brennan MF. Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer. 1999;86:2045\u201352.","journal-title":"Cancer"},{"key":"1148_CR10","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.ejso.2015.04.016","volume":"41","author":"XD He","year":"2015","unstructured":"He XD, Zhang YB, Wang L, Tian ML, Liu W, Qu Q, Li BL, Hong T, Li NC, Na YQ. Prognostic factors for the recurrence of sporadic desmoid-type fibromatosis after macroscopically complete resection: analysis of 114 patients at a single institution. Eur J Surg Oncol. 2015;41:1013\u20139.","journal-title":"Eur J Surg Oncol"},{"key":"1148_CR11","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.ejso.2014.02.226","volume":"40","author":"N Eastley","year":"2014","unstructured":"Eastley N, Aujla R, Silk R, Richards CJ, McCulloch TA, Esler CP, Ashford RU. Extra-abdominal desmoid fibromatosis\u2014a sarcoma unit review of practice, long term recurrence rates and survival. Eur J Surg Oncol. 2014;40:1125\u201330.","journal-title":"Eur J Surg Oncol"},{"key":"1148_CR12","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1002\/cncr.28271","volume":"119","author":"C Colombo","year":"2013","unstructured":"Colombo C, Miceli R, Lazar AJ, Perrone F, Pollock RE, Le Cesne A, Hartgrink HH, Cleton-Jansen AM, Domont J, Bovee JV, et al. CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study. Cancer. 2013;119:3696\u2013702.","journal-title":"Cancer"},{"key":"1148_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12957-015-0450-8","volume":"13","author":"YF Wang","year":"2015","unstructured":"Wang YF, Guo W, Sun KK, Yang RL, Tang XD, Ji T, Tang S. Postoperative recurrence of desmoid tumors: clinical and pathological perspectives. World J Surg Oncol. 2015;13:26.","journal-title":"World J Surg Oncol"},{"key":"1148_CR14","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.ejso.2016.06.396","volume":"42","author":"D Ma","year":"2016","unstructured":"Ma D, Li S, Fu R, Zhang Z, Cui Y, Liu H, Meng Y, Wang W, Bi Y, Xiao Y. Long-term outcomes of 47 patients with aggressive fibromatosis of the chest treated with surgery. Eur J Surg Oncol. 2016;42:1693\u20138.","journal-title":"Eur J Surg Oncol"},{"key":"1148_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1590\/1413-785220162403142182","volume":"24","author":"LE Teixeira","year":"2016","unstructured":"Teixeira LE, Arantes EC, Villela RF, Soares CB, Costa RB, Andrade MA. Extra-abdominal desmoid tumor: local recurrence and treatment options. Acta Ortop Bras. 2016;24:147\u201350.","journal-title":"Acta Ortop Bras"},{"key":"1148_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s13193-012-0146-2","volume":"3","author":"R Ramamurthy","year":"2012","unstructured":"Ramamurthy R, Arumugam B, Ramanandham B. Recurrence patterns and management options in aggressive fibromatosis. Indian J Surg Oncol. 2012;3:222\u20137.","journal-title":"Indian J Surg Oncol"},{"key":"1148_CR17","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1093\/annonc\/mdt254","volume":"24","author":"RB Keus","year":"2013","unstructured":"Keus RB, Nout RA, Blay JY, de Jong JM, Hennig I, Saran F, Hartmann JT, Sunyach MP, Gwyther SJ, Ouali M, et al. Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis\u2014an EORTC STBSG and ROG study (EORTC 62991\u201322998). Ann Oncol. 2013;24:2672\u20136.","journal-title":"Ann Oncol"},{"key":"1148_CR18","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.otohns.2006.10.012","volume":"136","author":"LG Morris","year":"2007","unstructured":"Morris LG, Sikora AG, Kuriakose MA, DeLacure MD. Tamoxifen therapy for aggressive fibromatosis of the posterior triangle of the neck. Otolaryngol Head Neck Surg. 2007;136:674\u20136.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1148_CR19","doi-asserted-by":"publisher","first-page":"E246","DOI":"10.1002\/hed.23092","volume":"35","author":"MP Hendriks","year":"2013","unstructured":"Hendriks MP, Driessen CM, van Laarhoven HW, Janssens GO, Verbist BM, van der Graaf WT, Slootweg PJ, Merkx MA, van Herpen CM. Aggressive fibromatosis in the head and neck region: benign tumor with often mutilating effects. Head Neck. 2013;35:E246\u201350.","journal-title":"Head Neck"},{"key":"1148_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s10147-005-0543-4","volume":"11","author":"T Ohashi","year":"2006","unstructured":"Ohashi T, Shigematsu N, Kameyama K, Kubo A. Tamoxifen for recurrent desmoid tumor of the chest wall. Int J Clin Oncol. 2006;11:150\u20132.","journal-title":"Int J Clin Oncol"},{"key":"1148_CR21","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/1097-0142(19910301)67:5<1443::AID-CNCR2820670530>3.0.CO;2-X","volume":"67","author":"DJ Sportiello","year":"1991","unstructured":"Sportiello DJ, Hoogerland DL. A recurrent pelvic desmoid tumor successfully treated with tamoxifen. Cancer. 1991;67:1443\u20136.","journal-title":"Cancer"},{"key":"1148_CR22","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/S0090-4295(96)00026-X","volume":"47","author":"JK Izes","year":"1996","unstructured":"Izes JK, Zinman LN, Larsen CR. Regression of large pelvic desmoid tumor by tamoxifen and sulindac. Urology. 1996;47:756\u20139.","journal-title":"Urology"},{"key":"1148_CR23","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/cncr.11937","volume":"100","author":"A Hansmann","year":"2004","unstructured":"Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer. 2004;100:612\u201320.","journal-title":"Cancer"},{"key":"1148_CR24","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5858\/2000-124-0276-FOTB","volume":"124","author":"M Devouassoux-Shisheboran","year":"2000","unstructured":"Devouassoux-Shisheboran M, Schammel MD, Man YG, Tavassoli FA. Fibromatosis of the breast: age-correlated morphofunctional features of 33 cases. Arch Pathol Lab Med. 2000;124:276\u201380.","journal-title":"Arch Pathol Lab Med"},{"key":"1148_CR25","first-page":"16","volume":"6","author":"MJ Plaza","year":"2012","unstructured":"Plaza MJ, Yepes M. Breast fibromatosis response to tamoxifen: dynamic MRI findings and review of the current treatment options. J Radiol Case Rep. 2012;6:16\u201323.","journal-title":"J Radiol Case Rep"},{"key":"1148_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1053\/hupa.2002.30196","volume":"33","author":"SC Abraham","year":"2002","unstructured":"Abraham SC, Reynolds C, Lee JH, Montgomery EA, Baisden BL, Krasinskas AM, Wu TT. Fibromatosis of the breast and mutations involving the APC\/beta-catenin pathway. Hum Pathol. 2002;33:39\u201346.","journal-title":"Hum Pathol"},{"key":"1148_CR27","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1634\/theoncologist.2012-0449","volume":"18","author":"JT Mullen","year":"2013","unstructured":"Mullen JT, DeLaney TF, Rosenberg AE, Le L, Iafrate AJ, Kobayashi W, Szymonifka J, Yeap BY, Chen YL, Harmon DC, et al. \u03b2-Catenin mutation status and outcomes in sporadic desmoid tumors. Oncologist. 2013;18:1043\u20139.","journal-title":"Oncologist"},{"key":"1148_CR28","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers H, Nusse R. Wnt\/beta-catenin signaling and disease. Cell. 2012;149:1192\u2013205.","journal-title":"Cell"},{"key":"1148_CR29","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1158\/1078-0432.CCR-07-0336","volume":"13","author":"S Signoroni","year":"2007","unstructured":"Signoroni S, Frattini M, Negri T, Pastore E, Tamborini E, Casieri P, Orsenigo M, Da Riva L, Radice P, Sala P, et al. Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis. Clin Cancer Res. 2007;13:5034\u201340.","journal-title":"Clin Cancer Res"},{"key":"1148_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1746-1596-9-14","volume":"9","author":"M Emori","year":"2014","unstructured":"Emori M, Kaya M, Mitsuhashi T, Asanuma H, Yamashita T. Desmoid tumor-associated pain is dependent on mast cell expression of cyclooxygenase-2. Diagn Pathol. 2014;9:14.","journal-title":"Diagn Pathol"},{"key":"1148_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/mccm.6.3.155.156","volume":"6","author":"L Hardell","year":"2000","unstructured":"Hardell L, Breivald M, Hennerdal S, Fernberg JO, Strander H. Shrinkage of desmoid tumor with interferon alfa treatment: a case report. Cytokines Cell Mol Ther. 2000;6:155\u20136.","journal-title":"Cytokines Cell Mol Ther"},{"key":"1148_CR32","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1080\/028418699432680","volume":"38","author":"JO Fernberg","year":"1999","unstructured":"Fernberg JO, Brosjo O, Larsson O, Soderlund V, Strander H. Interferon-induced remission in aggressive fibromatosis of the lower extremity. Acta Oncol. 1999;38:971\u20132.","journal-title":"Acta Oncol"},{"key":"1148_CR33","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1097\/AOG.0000000000001158","volume":"126","author":"F Arien","year":"2015","unstructured":"Arien F, Aleman JM, Op de Beeck B, Tjalma WA. Treatment of aggressive pelvic fibromatosis with interferon. Obstet Gynecol. 2015;126:1219\u201321.","journal-title":"Obstet Gynecol"},{"key":"1148_CR34","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ijom.2004.01.011","volume":"33","author":"JD Raguse","year":"2004","unstructured":"Raguse JD, Gath HJ, Oettle H, Bier J. Interferon-induced remission of rapidly growing aggressive fibromatosis in the temporal fossa. Int J Oral Maxillofac Surg. 2004;33:606\u20139.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"1148_CR35","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.jaad.2007.07.019","volume":"59","author":"G Stengel","year":"2008","unstructured":"Stengel G, Metze D, Dorflinger B, Luger TA, Bohm M. Treatment of extra-abdominal aggressive fibromatosis with pegylated interferon. J Am Acad Dermatol. 2008;59:S7\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"1148_CR36","doi-asserted-by":"publisher","first-page":"7124","DOI":"10.1158\/0008-5472.CAN-07-0686","volume":"67","author":"SS Tjandra","year":"2007","unstructured":"Tjandra SS, Hsu C, Goh YI, Gurung A, Poon R, Nadesan P, Alman BA. IFN-\u03b2 signaling positively regulates tumorigenesis in aggressive fibromatosis, potentially by modulating mesenchymal progenitors. Cancer Res. 2007;67:7124\u201331.","journal-title":"Cancer Res"},{"key":"1148_CR37","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00280-009-1010-0","volume":"64","author":"KM Skubitz","year":"2009","unstructured":"Skubitz KM, Manivel JC, Clohisy DR, Frolich JW. Response of imatinib-resistant extra-abdominal aggressive fibromatosis to sunitinib: case report and review of the literature on response to tyrosine kinase inhibitors. Cancer Chemother Pharmacol. 2009;64:635\u201340.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1148_CR38","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1158\/1078-0432.CCR-10-3322","volume":"17","author":"MM Gounder","year":"2011","unstructured":"Gounder MM, Lefkowitz RA, Keohan ML, D\u2019Adamo DR, Hameed M, Antonescu CR, Singer S, Stout K, Ahn L, Maki RG. Activity of sorafenib against desmoid tumor\/deep fibromatosis. Clin Cancer Res. 2011;17:4082\u201390.","journal-title":"Clin Cancer Res"},{"key":"1148_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10637-013-0059-0","volume":"32","author":"JC Jo","year":"2014","unstructured":"Jo JC, Hong YS, Kim KP, Lee JL, Lee J, Park YS, Kim SY, Ryu JS, Lee JS, Kim TW. A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis. Invest New Drugs. 2014;32:369\u201376.","journal-title":"Invest New Drugs"},{"key":"1148_CR40","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/SLA.0000000000000224","volume":"259","author":"M Fiore","year":"2014","unstructured":"Fiore M, Coppola S, Cannell AJ, Colombo C, Bertagnolli MM, George S, Le Cesne A, Gladdy RA, Casali PG, Swallow CJ, et al. Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk. Ann Surg. 2014;259:973\u20138.","journal-title":"Ann Surg"},{"key":"1148_CR41","unstructured":"European Medicines Agency. Scientific Discussion on Sunitinib. 2014. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Summary_for_the_public\/human\/000687\/WC500057689.pdf . Accessed 29 Oct 2016."},{"key":"1148_CR42","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1177\/0192623308326151","volume":"36","author":"S Patyna","year":"2008","unstructured":"Patyna S, Arrigoni C, Terron A, Kim TW, Heward JK, Vonderfecht SL, Denlinger R, Turnquist SE, Evering W. Nonclinical safety evaluation of sunitinib: a potent inhibitor of VEGF, PDGF, KIT, FLT3, and RET receptors. Toxicol Pathol. 2008;36:905\u201316.","journal-title":"Toxicol Pathol"},{"key":"1148_CR43","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1182\/blood-2007-10-114900","volume":"111","author":"SM Pye","year":"2008","unstructured":"Pye SM, Cortes J, Ault P, Hatfield A, Kantarjian H, Pilot R, Rosti G, Apperley JF. The effects of imatinib on pregnancy outcome. Blood. 2008;111:5505\u20138.","journal-title":"Blood"},{"key":"1148_CR44","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/annonc\/mdj065","volume":"17","author":"DR Choudhary","year":"2006","unstructured":"Choudhary DR, Mishra P, Kumar R, Mahapatra M, Choudhry VP. Pregnancy on imatinib: fatal outcome with meningocele. Ann Oncol. 2006;17:178\u20139.","journal-title":"Ann Oncol"},{"key":"1148_CR45","doi-asserted-by":"publisher","first-page":"405","DOI":"10.5505\/tjh.2012.82542","volume":"29","author":"MJ Webb","year":"2012","unstructured":"Webb MJ, Jafta D. Imatinib use in pregnancy. Turk J Haematol. 2012;29:405\u20138.","journal-title":"Turk J Haematol"},{"key":"1148_CR46","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1600-0609.2005.00420.x","volume":"74","author":"S AlKindi","year":"2005","unstructured":"AlKindi S, Dennison D, Pathare A. Imatinib in pregnancy. Eur J Haematol. 2005;74:535\u20137.","journal-title":"Eur J Haematol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-017-1148-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T11:58:25Z","timestamp":1658923105000},"score":1,"resource":{"primary":{"URL":"http:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-017-1148-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,18]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1148"],"URL":"https:\/\/doi.org\/10.1186\/s12957-017-1148-x","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,18]]},"article-number":"86"}}